S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
NASDAQ:VBIV

VBI Vaccines - VBIV Earnings Date, Estimates & Call Transcripts

$1.22
+0.12 (+10.91%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.13
$1.25
50-Day Range
$0.66
$1.22
52-Week Range
$0.64
$3.81
Volume
1.57 million shs
Average Volume
2.29 million shs
Market Capitalization
$315.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(May. 9)
-$0.08
Consensus EPS
(May. 9)
-$0.08
Last Year's Q2 EPS
(5/10/2021)
-$0.07
Skip Charts & View Estimated and Actual Earnings Data

VBIV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VBIV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

VBI Vaccines Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.08)($0.08)($0.08)
Q2 20222($0.08)($0.06)($0.07)
Q3 20222($0.08)($0.08)($0.08)
Q4 20222($0.09)($0.08)($0.09)
FY 20228($0.33)($0.30)($0.32)
Q1 20231($0.08)($0.08)($0.08)
Q2 20231($0.07)($0.07)($0.07)
Q3 20231($0.07)($0.07)($0.07)
Q4 20231($0.07)($0.07)($0.07)
FY 20234($0.29)($0.29)($0.29)

VBIV Earnings Date and Information

VBI Vaccines last issued its earnings results on May 9th, 2022. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.08). The business had revenue of $0.13 million for the quarter, compared to the consensus estimate of $0.13 million. VBI Vaccines has generated ($0.39) earnings per share over the last year (($0.39) diluted earnings per share). Earnings for VBI Vaccines are expected to grow in the coming year, from ($0.37) to ($0.26) per share. VBI Vaccines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off prior year's report dates.

VBI Vaccines Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2022
(Estimated)
        
5/9/2022Q1 2022($0.08)($0.08)($0.08)$0.13 million$0.13 million
3/7/2022Q4 2021($0.07)($0.07)($0.07)$0.14 million$0.08 million
11/8/20219/30/2021($0.07)($0.06)+$0.01($0.06)$0.26 million$0.11 million
8/1/20216/30/2021($0.07)($0.07)($0.07)$0.55 million$0.14 million
5/10/20213/31/2021($0.06)($0.07)($0.01)($0.07)$0.51 million$0.30 million
3/1/202112/31/2020($0.06)($0.06)($0.06)$0.44 million$0.16 million
11/2/20209/30/2020($0.05)($0.06)($0.01)($0.06)$0.36 million$0.30 million
7/31/20206/30/2020($0.04)($0.04)($0.04)$0.86 million$0.18 million
5/6/20203/31/2020($0.06)($0.05)+$0.01($0.05)$0.83 million$0.42 million
3/5/202012/31/2019($0.06)($0.02)+$0.04($0.02)$0.97 million$0.57 million
11/6/2019Q3($0.1270)($0.15)($0.0230)($0.15)$0.90 million$0.65 million
8/9/20196/30/2019($0.15)($0.13)+$0.02($0.13)$0.60 million$0.64 million
5/1/2019Q1($0.1530)($0.15)+$0.0030($0.15)$0.20 million$0.36 million
2/25/2019Q4 2018($0.19)($0.28)($0.09)($0.28)$2.13 million$2.68 million
11/9/20189/30/2018($0.22)($0.24)($0.02)($0.24)$0.24 million$0.26 million
7/26/20186/30/2018($0.17)($0.26)($0.09)($0.26)$0.23 million
5/1/20183/31/2018($0.16)($0.19)($0.03)($0.19)$0.21 million$0.18 million
11/13/2017Q3 2017($0.23)($0.24)($0.01)($0.24)$0.15 million$0.19 million
7/31/2017Q2 2017($0.22)($0.22)($0.22)$0.14 million$0.34 million
5/15/2017Q1 2017($0.15)($0.22)($0.07)($0.22)$0.09 million$0.13 million
8/15/2016Q2 2016($0.23)($0.23)($0.23)$0.08 million












VBI Vaccines Earnings - Frequently Asked Questions

When is VBI Vaccines's earnings date?

VBI Vaccines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates. Learn more on VBIV's earnings history.

Did VBI Vaccines beat their earnings estimates last quarter?

In the previous quarter, VBI Vaccines (NASDAQ:VBIV) reported ($0.08) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.08). Learn more on analysts' earnings estimate vs. VBIV's actual earnings.

How much revenue does VBI Vaccines generate each year?

VBI Vaccines (NASDAQ:VBIV) has a recorded annual revenue of $630,000.00.

How much profit does VBI Vaccines generate each year?

VBI Vaccines (NASDAQ:VBIV) has a recorded net income of -$69.75 million. VBIV has generated -$0.39 earnings per share over the last four quarters.

What is VBI Vaccines's EPS forecast for next year?

VBI Vaccines's earnings are expected to grow from ($0.37) per share to ($0.26) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:VBIV) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.